Life Healthcare Group Holdings Limited (LTGHF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 2.53 means the share price is 2.53 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $987M is the value of all shares combined. Beta 0.08: the stock has moved about 92% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLife Healthcare Group Holdings Limited (LTGHF) trades at $0.69. Life Healthcare Group Holdings Limited operates private hospitals and complementary healthcare services across South Africa, Canada, the United Kingdom, and Europe. Market cap: $987M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for LTGHF: LTGHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LTGHF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
LTGHF: 2/2 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Life Healthcare Group Holdings Limited (LTGHF) Healthcare & Pipeline Overview
Life Healthcare Group Holdings Limited, a global healthcare provider with a $987M market cap and 15.3% profit margin, operates hospitals and complementary services across multiple continents. Its high dividend yield of 26.00% and low beta of 0.08 position it as a potentially stable investment within the healthcare sector.
What Is the Investment Thesis for LTGHF?
Life Healthcare presents a compelling, albeit high-yield, investment case based on its established presence in diverse healthcare markets and a P/E ratio of 2.53. The company's 15.3% profit margin and 25.6% gross margin indicate operational efficiency. Growth catalysts include expansion of complementary services and strategic investments in diagnostic technologies. However, investors should carefully consider the sustainability of the 26.00% dividend yield, particularly in light of potential regulatory changes and economic conditions in its operating regions. The low beta of 0.08 suggests lower volatility compared to the broader market, but also potentially limits upside during market rallies. Monitoring the company's ability to maintain profitability and manage its debt levels is crucial for assessing long-term value.
Based on FMP financials and quantitative analysis
LTGHF Key Highlights
Market capitalization of $987M, reflecting its size and investor valuation in the healthcare sector.
- P/E ratio of 2.53, suggesting the stock might be undervalued compared to its earnings.
- Profit margin of 15.3%, indicating efficient operations and profitability.
- Gross margin of 25.6%, reflecting the company's ability to control production costs.
- Dividend yield of 26.00%, offering a substantial return to shareholders, but requires careful evaluation of sustainability.
Who Are LTGHF's Competitors?
LTGHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EXETF Extendicare Inc. | $22.20 | -0.05% | $2.11B | — |
| LWSCF Sienna Senior Living Inc. | $14.39 | -0.51% | $1.43B | — |
| NWKHY Netcare Limited | $11.45 | 0.00% | $1.35B | — |
| PHCI Panamera Holdings Corporation | $2.50 | 0.00% | $185M | — |
| RAFLF Raffles Medical Group Ltd | $0.67 | 0.00% | $1.23B | — |
| USPH U.S. Physical Therapy, Inc. | $78.52 | +1.04% | $1.19B | 605-pillar |
| AMN AMN Healthcare Services, Inc. | $33.47 | +1.27% | $1.30B | 935-pillar |
| PNTG The Pennant Group, Inc. | $39.55 | +0.64% | $1.38B | 695-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LTGHF's Key Strengths?
Diversified geographic presence in South Africa, Canada, the UK, and Europe.
- Comprehensive range of healthcare services, including acute care, mental health, and diagnostics.
- Established relationships with insurance providers and government healthcare programs.
- Strong brand reputation and patient trust.
What Are LTGHF's Weaknesses?
Exposure to regulatory changes and economic conditions in multiple countries.
- High dividend yield may not be sustainable in the long term.
- Dependence on insurance reimbursements and government funding.
- Potential for increased competition from other private hospital groups.
What Could Drive LTGHF Stock Higher?
Expansion of complementary services, such as mental healthcare and rehabilitation, driving revenue growth.
- Strategic investments in advanced diagnostic technologies and radiopharmaceuticals, enhancing service offerings.
- Potential geographic expansion in emerging markets with growing healthcare needs.
- Development of integrated healthcare solutions that combine hospital care, complementary services, and employee health solutions.
What Are the Key Risks for LTGHF?
Financial-distress signal — its Altman Z-Score of -7.99 sits in the distress zone (elevated bankruptcy risk).
- Economic downturns and reduced healthcare spending impacting revenue.
- Changes in government regulations and insurance policies affecting reimbursement rates.
- Increased competition from other private hospital groups and healthcare providers.
- Medical malpractice claims and litigation leading to financial losses.
- High dividend yield may not be sustainable in the long term.
What Are the Growth Opportunities for LTGHF?
- Expansion of Complementary Services: Life Healthcare has the opportunity to expand its complementary services, such as Life Esidimeni, focusing on chronic mental healthcare, frail care, and rehabilitation. The demand for these services is increasing due to aging populations and growing awareness of mental health issues. By investing in infrastructure and skilled personnel, Life Healthcare can capture a larger share of this market, potentially increasing revenue by 10-15% over the next three years.
- Strategic Investments in Diagnostic Technologies: Investing in advanced diagnostic imaging technologies, such as MRI and CT scanners, and the development of radiopharmaceuticals for PET-CT diagnostics, can drive growth. The global diagnostic imaging market is projected to reach $36.4 billion by 2027. Life Healthcare can enhance its diagnostic capabilities and attract more patients by offering cutting-edge services, leading to a 12-18% increase in revenue from this segment.
- Geographic Expansion in Emerging Markets: Life Healthcare can explore opportunities for geographic expansion in emerging markets with growing healthcare needs. These markets often lack adequate healthcare infrastructure, presenting a significant opportunity for private hospital groups. By establishing a presence in these regions, Life Healthcare can diversify its revenue streams and tap into new patient pools, potentially increasing overall revenue by 8-12% over the next five years.
- Development of Integrated Healthcare Solutions: Life Healthcare can develop integrated healthcare solutions that combine hospital care, complementary services, and employee health solutions. By offering a comprehensive suite of services, the company can attract and retain more patients and corporate clients. This integrated approach can lead to improved patient outcomes, reduced healthcare costs, and increased revenue for Life Healthcare, with a potential revenue increase of 10-15% over the next three years.
- Leveraging Technology for Improved Efficiency: Implementing advanced technologies, such as telemedicine, AI-powered diagnostics, and electronic health records, can improve operational efficiency and patient care. These technologies can streamline processes, reduce costs, and enhance the patient experience. By embracing technological innovation, Life Healthcare can gain a competitive advantage and drive growth, potentially reducing operational costs by 5-10% and increasing patient satisfaction scores.
What Are LTGHF's Competitive Advantages?
- Established presence in multiple geographic markets, providing diversification and stability.
- Comprehensive range of healthcare services, catering to diverse patient needs.
- Strong relationships with insurance companies and government healthcare programs.
- Investments in advanced diagnostic technologies and radiopharmaceuticals, enhancing service offerings.
What Does LTGHF Do?
Founded in 1983 and headquartered in Johannesburg, South Africa, Life Healthcare Group Holdings Limited has evolved into a multinational healthcare provider. Originally known as Afrox Healthcare Limited, the company rebranded in 2005 to reflect its broader strategic vision. Life Healthcare operates through two primary segments: Hospitals and Complementary Services, and Healthcare Services. The Hospitals and Complementary Services segment provides a comprehensive suite of acute hospital care, encompassing various medical disciplines such as oncology, cardiology, neurology, orthopedics, and pediatrics. Complementary services include mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programs under the Life Esidimeni banner. The Healthcare Services segment focuses on occupational and primary healthcare services, as well as employee wellness programs through Life Employee Health Solutions. Additionally, Life Healthcare offers advanced diagnostic imaging services, including MRI and CT scans, and develops and distributes radiopharmaceuticals for PET-CT diagnostics. The company's geographic footprint spans South Africa, Canada, the United Kingdom, and other European countries, positioning it as a significant player in the international healthcare landscape.
What Products and Services Does LTGHF Offer?
- Operates private hospitals in South Africa, Canada, the United Kingdom, and Europe.
- Provides acute hospital care services across various medical disciplines.
- Offers complementary services, including mental healthcare, rehabilitation, and frail care.
- Provides occupational and primary healthcare services to employees.
- Offers diagnostic imaging services, including MRI and CT scans.
- Develops and distributes radiopharmaceuticals for PET-CT diagnostics.
- Provides Life Esidimeni services, such as chronic mental healthcare and substance abuse recovery programs.
- Offers Life Employee Health Solutions, including on-site occupational and primary healthcare services and employee wellness programs.
How Does LTGHF Make Money?
- Generates revenue from providing hospital services to patients.
- Earns income from complementary healthcare services, such as mental healthcare and rehabilitation.
- Receives payments from insurance companies and government healthcare programs.
- Generates revenue from diagnostic imaging services and radiopharmaceutical sales.
What Industry Does LTGHF Operate In?
Life Healthcare operates within the global healthcare industry, which is experiencing growth driven by aging populations, technological advancements, and increasing demand for quality care. The private hospital sector, in particular, is influenced by government regulations, insurance coverage, and economic conditions. Life Healthcare competes with other private hospital groups and healthcare service providers, including EXETF, LWSCF, NWKHY, PHCI, and RAFLF. The company's ability to differentiate through specialized services, geographic expansion, and operational efficiency will be key to maintaining its competitive position in this dynamic landscape.
Who Are LTGHF's Key Customers?
- Patients seeking acute hospital care and specialized medical treatments.
- Individuals requiring mental healthcare, rehabilitation, and frail care services.
- Corporations seeking occupational and primary healthcare services for their employees.
- Insurance companies and government healthcare programs that reimburse healthcare costs.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 164 days ago
- ● No analyst coverage
- ● Reported in ZAR, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 20 snapshots
| 2026-08-23 | 44 |
| 2026-08-27 | 44 |
| 2026-08-31 | 44 |
| 2026-09-04 | 44 |
| 2026-09-08 | 44 |
| 2026-09-11 | 44 |
What changed?
The score has stayed at 44.
Over the same 19 days the stock moved +0.0%.
Life Healthcare Group Holdings Limited (LTGHF) Valuation Context
Valued at $987M, LTGHF is classified as a small-cap stock.
LTGHF Revenue & Earnings Trend
In Q2 FY2026, LTGHF generated $763.4M in top-line revenue, marking a sequential increase of 0.8%. The company recorded net income of $47.4M, with diluted EPS of $0.03. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare.
Company Profile
Life Healthcare Group Holdings Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Johannesburg, ZA. The company is led by CEO Peter Gerard Wharton-Hood Harvard. LTGHF has traded publicly since 2011.
Key Financial Metrics
Return on equity for Life Healthcare Group Holdings Limited stands at 60.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 29.3%, showing how much profit it generates from its asset base. LTGHF trades at a trailing price-to-earnings ratio of 2.53, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 12.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.45 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 45.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Life Healthcare Group Holdings Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -7.99 places it in the distress zone, a signal of elevated financial risk.
LTGHF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified geographic presence in South Africa, Canada, the UK, and Europe.
- Comprehensive range of healthcare services, including acute care, mental health, and diagnostics.
- Established relationships with insurance providers and government healthcare programs.
- Strong brand reputation and patient trust.
Bear Case
- Exposure to regulatory changes and economic conditions in multiple countries.
- High dividend yield may not be sustainable in the long term.
- Dependence on insurance reimbursements and government funding.
- Potential for increased competition from other private hospital groups.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $763M | $47M | $0.03 |
| Q2 FY2025 | $758M | -$137M | -$0.09 |
| Q4 FY2024 | $843M | $82M | -$0.10 |
Q2 FY2026 · filed 31 Mar 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Converted to USD from ZAR at today's rate
LTGHF Latest News
No recent news available for LTGHF.
LTGHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LTGHF.
Price Targets
Wall Street price target analysis for LTGHF.
LTGHF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for LTGHF; grades run from A+ (80-100) to F (below 30).
Leadership: Peter Gerard Wharton-Hood Harvard
CEO
Peter Gerard Wharton-Hood's background includes a degree from Harvard University. He has extensive experience in the healthcare industry, with a focus on strategic leadership and operational management. Before joining Life Healthcare, he held various leadership positions in other healthcare organizations, where he was responsible for driving growth, improving efficiency, and enhancing patient care. His expertise spans across hospital operations, financial management, and strategic planning.
Track Record: Since becoming CEO, Peter Gerard Wharton-Hood has focused on expanding Life Healthcare's geographic footprint and enhancing its service offerings. Key achievements include strategic investments in diagnostic technologies and the development of integrated healthcare solutions. He has also prioritized improving operational efficiency and patient satisfaction, leading to increased profitability and market share. His leadership has been instrumental in navigating the challenges of the healthcare industry and positioning Life Healthcare for long-term success.
LTGHF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) markets. Companies in this tier often have limited or no financial disclosure and may not meet minimum listing requirements. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same stringent regulatory oversight, leading to higher risks for investors. Information availability is typically scarce, making due diligence challenging. This tier is often populated by shell companies, defunct businesses, or companies with questionable operations.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in LTGHF.
- Low trading volume and wide bid-ask spread can lead to price volatility and execution challenges.
- Lack of regulatory oversight on the OTC Other tier increases the potential for fraud or mismanagement.
- The company may not meet minimum listing requirements, indicating potential financial or operational issues.
- Limited information availability makes it difficult to assess the company's true value and prospects.
- Verify the company's registration and legal status.
- Attempt to obtain and review any available financial statements.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with relevant regulations.
- Consult with a financial advisor to assess the risks and potential rewards.
- Understand the potential for limited liquidity and price volatility.
- Established presence in multiple geographic markets (South Africa, Canada, UK, Europe).
- Comprehensive range of healthcare services offered.
- History of operations dating back to 1983.
- Market capitalization of $987M, suggesting some level of investor confidence.
Life Healthcare Group Holdings Limited Healthcare Stock: Key Questions Answered
Is LTGHF a good stock?
Stock Expert AI does not rate LTGHF buy, sell or hold. Life Healthcare Group Holdings Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about LTGHF stock?
Analyst coverage of LTGHF stock is limited due to its OTC listing. Key valuation metrics include a P/E ratio of 2.53 and a dividend yield of 26.00%.
What are the key factors to evaluate for LTGHF?
Evaluate LTGHF on fundamentals, analyst consensus, and risk factors. P/E: 2.53x vs the S&P 500's ~20-25x. Life Healthcare presents a compelling, albeit high-yield, investment case based on its established presence in diverse healthcare markets and a P/E ratio of 2.53. Not financial advice.
How frequently does LTGHF data refresh on this page?
LTGHF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.
What has driven LTGHF's recent stock price performance?
Life Healthcare Group Holdings Limited (LTGHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified geographic presence in South Africa, Canada, the UK, and Europe. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LTGHF overvalued or undervalued right now?
Life Healthcare Group Holdings Limited (LTGHF) trades at 2.53x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of LTGHF?
Yes, most major brokerages offer fractional shares of Life Healthcare Group Holdings Limited (LTGHF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track LTGHF's earnings and financial reports?
Life Healthcare Group Holdings Limited (LTGHF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for LTGHF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- Analyst coverage may be limited due to the company's OTC listing.